BAHA Osseointegrated denied as not FDA-approved for this use by Cigna?
Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for baha osseointegrated are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on BAHA Osseointegrated
## Why Cigna Denied Your BAHA as "Not FDA-Approved" — and Why You Can Appeal
Bone-anchored hearing aids (BAHAs) and osseointegrated auditory implant systems include both the implantable fixture and the external sound processor. Cigna occasionally issues "not FDA-approved" denials when the specific processor model or a software upgrade is newer than the version listed in their coverage policy, or when a combination of components is coded in a way the system does not recognize as a cleared device. In most cases the implant system as a whole carries FDA 510(k) clearance or premarket approval — the denial is frequently a coding or policy-update mismatch, not a reflection of the device's regulatory status.
## Federal Appeal Rights
Because this is a coverage denial (not an exclusion), you have full appeal rights:
- Internal appeal — Cigna must decide within 30 days (pre-service) or 60 days (post-service). Submit a written appeal with supporting documentation.
- External review (ACA §2719 / ERISA §503) — If Cigna upholds the denial, you may request an independent external review through an accredited Independent Review Organization (IRO). The standard window to request external review is typically within 4 months of the final internal denial notice. An expedited external review is available when the standard timeline would seriously jeopardize your health.
## Documentation to Gather
- FDA clearance letter or 510(k) summary for the exact device model — your audiologist or the manufacturer's medical affairs team can supply this.
- Prescribing/ordering physician letter confirming FDA-cleared status and medical necessity, citing the specific model number.
- Cigna's own coverage policy (obtain the current version number and effective date from Cigna directly) — compare the listed device categories to your prescribed system and note any discrepancy.
- Audiological evaluation documenting the type and degree of hearing loss and why this device category is indicated.
- Prior treatment history — any conventional hearing aids tried, durations of use, and documented outcomes or contraindications.
## Criteria-Mapping Structure
For each requirement in Cigna's coverage policy, create a table row:
| Policy Requirement | Supporting Chart Evidence | |---|---| | Device bears FDA clearance/approval | [Attach FDA document + device model number] | | Diagnosis meets covered indication | [Audiologist report, diagnosis codes] | | Ordered by qualified provider | [Otolaryngologist or audiology order on file] |
## Key Appeal Argument
Your appeal letter should lead with the FDA clearance documentation and request that Cigna identify the specific regulatory deficiency — if none exists, the stated denial reason is factually unsupported and the claim must be reconsidered on medical-necessity grounds. Attach the manufacturer's FDA clearance summary as Exhibit A.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →